Skip to main content

Table 1 Patient characteristics

From: Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs

 

Total (N)

SUR + TKI (N)

RT + TKI (N)

RT + CHE (N)

p

Male/female

12/24

6/10

4/10

2/4

0.884

Age

 Median (range)

58 (39–72)

56.5 (39–68)

57.5 (45–72)

59 (46–63)

0.767

ECOG PS

 0/1/2/3/4

20/12/4/0

12/4/0/0

6/5/3/0

2/3/1/0

0.057

RPA

 I/II/III

27/5

14/2/0

8/3/3

5/0/1

0.114

GPA

 1–2/2.5–3/3.5–4

2/20/14

0/7/9

2/8/4

0/5/1

0.264

EGFR m + type

 

6/10/0 (lung)

   

 21/19/others

15/20/1

6/9/0 (brain)

7/6/1

2/4/0

0.934

EGFR-TKI

 Gefitinib/erlotinib

21/19

12/4

9/5

0.539

RT

 SRS/WBRT

16/4

12/2

4/2

0.355